Baxter subsidiary Baxa hit by Class I recall of nutrition calculation software
This article was originally published in Clinica
Executive Summary
The US FDA has designated Baxa's warning over its Abacus total parenteral nutrition calculation software as a Class I recall, the most serious of its kind. Pharmacists use the software to create or calculate formulas for parenteral nutrition, which is given intravenously to patients who cannot eat or drink via the mouth. However, dosing errors can occur with the software if the wrong ordering template is used, which could potentially lead to serious adverse events or death.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.